Cargando…

Mendelian randomization applied to pharmaceutical use: the case of metformin and lung cancer

Detalles Bibliográficos
Autores principales:	Yarmolinsky, James, Bull, Caroline J, Walker, Venexia M, Nounu, Aayah, Davey Smith, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660135/ https://www.ncbi.nlm.nih.gov/pubmed/32356895 http://dx.doi.org/10.1093/ije/dyaa059

Ejemplares similares

Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study
por: Nounu, Aayah, et al.
Publicado: (2022)

On the use of Mendelian randomization to assess the consequences of metformin exposure
por: Williams, Dylan M
Publicado: (2020)

Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities
por: Walker, Venexia M, et al.
Publicado: (2017)

Commentary: Mendelian randomization analysis identifies circulating vitamin D as a causal risk factor for ovarian cancer
por: Bull, Caroline J, et al.
Publicado: (2016)

Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progression
por: Mitchell, Ruth E., et al.
Publicado: (2023)

Mendelian randomization does not support serum calcium in prostate cancer risk
por: Yarmolinsky, James, et al.
Publicado: (2018)

Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
por: Fang, Si, et al.
Publicado: (2023)

Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study
por: Zheng, Jie, et al.
Publicado: (2023)

Mendelian Randomization in Case Only Studies: A Promising Approach to be Applied With Caution
por: Mitchell, Ruth E., et al.
Publicado: (2018)

Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization
por: Taylor, Kurt, et al.
Publicado: (2019)

Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis
por: Yarmolinsky, James, et al.
Publicado: (2018)

Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study
por: Zheng, Jie, et al.
Publicado: (2022)

Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer
por: Wade, Kaitlin H., et al.
Publicado: (2022)

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study
por: Walker, Venexia M, et al.
Publicado: (2019)

Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
por: Yarmolinsky, James, et al.
Publicado: (2022)

Recent Developments in Mendelian Randomization Studies
por: Zheng, Jie, et al.
Publicado: (2017)

The association between sarcopenia and cirrhosis: a Mendelian randomization analysis
por: Ran, Shu, et al.
Publicado: (2023)

Mendelian randomization for studying the effects of perturbing drug targets
por: Gill, Dipender, et al.
Publicado: (2021)

Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
por: Zheng, Jie, et al.
Publicado: (2020)

Investigating the transparency of reporting in two-sample summary data Mendelian randomization studies using the MR-Base platform
por: Woolf, Benjamin, et al.
Publicado: (2022)

Gout and susceptibility and severity of COVID-19: A bidirectional Mendelian randomization analysis
por: Peng, Haoxin, et al.
Publicado: (2022)

Lung function, COPD and cognitive function: a multivariable and two sample Mendelian randomization study
por: Higbee, Daniel H., et al.
Publicado: (2021)

Effects of general and central adiposity on circulating lipoprotein, lipid, and metabolite levels in UK Biobank: A multivariable Mendelian randomization study
por: Bell, Joshua A., et al.
Publicado: (2022)

Mendelian randomization reveals potential causal candidates for COVID-19 in 123 blood metabolites
por: Qiu, Shizheng, et al.
Publicado: (2022)

Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study
por: Smith, Madeleine L., et al.
Publicado: (2023)

PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study
por: Lyall, Donald M., et al.
Publicado: (2021)

Bias in Mendelian randomization due to assortative mating
por: Hartwig, Fernando Pires, et al.
Publicado: (2018)

Addition of metformin to non‐small‐cell lung cancer patients with or without diabetes
por: Chen, Hua‐Fen, et al.
Publicado: (2022)

Mendelian randomization: genetic anchors for causal inference in epidemiological studies
por: Davey Smith, George, et al.
Publicado: (2014)

Evaluating the potential role of pleiotropy in Mendelian randomization studies
por: Hemani, Gibran, et al.
Publicado: (2018)

Assessing the protective role of allergic disease in gastrointestinal tract cancers using Mendelian randomization analysis
por: Yuan, Shuai, et al.
Publicado: (2020)

Longer Leukocyte Telomere Length Increases the Risk of Atrial Fibrillation: A Mendelian Randomization Study
por: Liu, Yaozhong, et al.
Publicado: (2022)

Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using Mendelian randomization
por: Gormley, Mark, et al.
Publicado: (2023)

Renoprotective effects of metformin
por: Nasri, Running Hamid
Publicado: (2013)

Metformin and Cancer Treatment
por: Di Mari, Annamaria, et al.
Publicado: (2015)

Association between 25 Hydroxyvitamin D Concentrations and the Risk of COVID-19: A Mendelian Randomization Study
por: LIU, Di, et al.
Publicado: (2021)

Does COVID-19 increase the risk of neuropsychiatric sequelae? Evidence from a mendelian randomization approach
por: Tirozzi, Alfonsina, et al.
Publicado: (2022)

IL1RA mediated the effects of aspirin on COVID-19 severity: A Mendelian randomization study
por: Liu, Xuxu, et al.
Publicado: (2023)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis
por: Yarmolinsky, James, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jlboflm40lh8dt2ienrlkaqo66